Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Cancer|April 1, 1990
The epidermal growth factor receptor and the prognosis of bladder cancerD E Neal, L Sharples, K Smith, et al.
Molecular Endocrinology (Baltimore, Md.)|October 24, 2000
Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filaminD M Ozanne, M E Brady, S Cook, et al.
British Journal of Cancer|February 13, 2001
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67V M Tut, K L Braithwaite, B Angus, et al.
British Journal of Cancer|June 4, 2009
UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancerM Unoki, J D Kelly, D E Neal, et al.
Oncogene|May 29, 1999
FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent diseaseT J Dorkin, M C Robinson, C Marsh, et al.
British Journal of Urology|August 1, 1997
Serum free prostate-specific antigen in the diagnosis of prostate cancerH Y Leung, L C Lai, J Day, et al.
British Journal of Urology|May 1, 1994
P53 expression, ploidy and progression in pT1 transitional cell carcinoma of the bladderD J Thomas, M C Robinson, R Charlton, et al.
Cancer Research|October 23, 1997
Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissueF C Hamdy, P Autzen, M C Robinson, et al.
British Journal of Urology|December 1, 1994
c-jun oncogene expression in transitional cell carcinoma of the urinary bladderD G Tiniakos, K Mellon, J J Anderson, et al.
The Journal of Urology|March 1, 1989
Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand bindingD E Neal, K Smith, J A Fennelly, et al.
Pageof 24